Turning science into business.
Companies that last start with a vision that improves people’s lives and a clear North Star. I help leaders and boards in life science and deep tech find theirs, bring the right people together and keep everyone moving toward it.
Where do you stand right now?
A decision is coming up
A board meeting, the next financing round, a partner to approach, or a team with a strong technology and too few customers. You get an experienced outside view on that one decision: we prepare it together, and I write it up afterwards.
See Your Next MoveA deal is on the table
A financing round, a licensing or partnering term sheet, an acquisition or a large customer contract, and the terms are about to be set. Over 26 years in leadership roles I have worked on these deals with the teams, from the IPO preparation at Nabriva to the Series B at Themis Bioscience, which MSD later acquired. You get support on your positioning, the follow-up and how you conduct yourself in the negotiation room.
See how deals get closedInvestors and partners need to find you
Investors, pharma partners and M&A teams now run their first check through search and AI agents. A company that publishes little drops off the long list. My PR process gives your leadership a lasting executive video portrait and places it where those checks happen.
See the PR processYou back companies and want an outside view for your CEOs
Life-science VC partners have placed me in their portfolio companies as board member and CFO. Today the quickest route is one prepared session for your CEO: ahead of a board meeting or a negotiation, or when the first customers and the sales pipeline are the bottleneck.
Send your CEO to Your Next MoveHow will AI change my business?
I have followed AI since 2014, when the first discussions about image analysis for diagnostics began. Since ChatGPT arrived in November 2022 I have worked with it every day, and since agents like OpenClaw appeared in late 2025 my own work runs on them. Along the way I completed the AI courses of the Anthropic and OpenAI Academies. The question I help leadership teams answer is a practical one: where does AI improve a result your business already measures, and how do you prove it?
See where AI fitsYou invest in listed companies
My public-market strategies invest in listed companies only. I publish each one as a wikifolio with an ISIN and a full public record.
View the portfoliosWhy I build
A vision people want to be part of
From spin-out to the next milestone, with the team
Vision, a clear North Star and the best people at one table. Over the years I learned that three things matter most in a company: a vision that improves other people’s lives, total clarity on the North Star, and bringing the best A-players together: customers, employees, investors and every other stakeholder the vision needs, with win-win deals negotiated between them. That is how a movement forms behind the vision and small teams grow, as Mike Maples Jr. and Peter Ziebelman describe in Pattern Breakers. Those companies start small and become unbeatable. The financials follow.
Building companies has fascinated me since the Commodore 64. It started with Kaiser and Hanse, and later Capitalism and Civilization, and it never let go. My tools grew from early entrepreneurial projects, like a magazine for my chess club and projects in my fraternities, then commercial school and an MBA from the University of Graz. Over 17 marathons and ultras and more than 40 years of martial arts philosophy, I refined them further. The principles I use every day come from there.
From corporate M&A to the moments that set a company’s course. I started in M&A at large corporations: Agrana, Atos Origin, Österreichische Post and One. Today I build life-science and deep-tech companies on the executive and board side, from spin-out to exit. CEOs, boards and investors bring me in for the next financing round, a licensing or partnering deal, the route to a listing or an acquisition, and the first customers for a new technology.
Active negotiation runs through all of it, and the show puts it on stage. Besides negotiating for companies from the front, as executive or advisory board member, or supporting them from the back, as advisor or executive coach with reflection and know-how, I have always brought people together. Before the pandemic I ran quarterly meetups and organised an investment conference in Vienna. During the pandemic I turned them into an online show, Beginner’s Mind. Every conversation brings CEOs, investors and executives to one table and shows how deals come together. The goal has stayed the same: help my business partners reach more investors, partners and executives.
New on the site
Deb Houry on leading in a crisis
Former Chief Medical Officer of the CDC and author of Triage, on deciding with incomplete data and when the best decision is to wait. Wednesday 25 November, 20:30 CET (14:30 ET), LinkedIn Live.
Article · 13 November 2026
Jensen Huang’s legacy: how NVIDIA made the AI age possible
Thirty-three years at the head of NVIDIA ended after two weeks of headlines. A tribute to three decisions that made the AI age possible: refusing to be a one-hit wonder, a chip tested before it existed, and CUDA on every gaming card.
Read the articleArticle · 12 November 2026
How to align a leadership team behind one goal: my corporate planning method, now as a free handbook
Planning season decides what next year will serve. A free handbook on the method behind the plan: one big vision, a few missions, the next six months in detail, and a monthly review that keeps every team on the same road.
Read the articleArticle · 11 November 2026
Why would a venture firm sign a $2.16 billion deal with a nine-month-old Chinese biotech?
Third Rock Ventures sold Thrive for up to $2.15 billion in 2020. Now a nine-month-old Beijing company announced an AI antibody collaboration with the firm worth up to $2.16 billion. How to read the number, and what it means for company builders.
Read the articleBeginner’s Mind
Long-form conversations with the people who build and finance deep tech and the life sciences. Each conversation goes to my network of 25,000+ VCs, M&A dealmakers and executives in Europe and the United States, and into the search engines and AI systems they use to find companies.
It ranks in the global top 10% of all podcasts and was #1 Deep Tech Podcast in 2025 and #8 Deep Tech Podcast in 2026.
- Eric RiesAuthor, The Lean Startup · EP 180
- Karl NehammerVice-President, European Investment Bank · EP 166
- Suzanne HeywoodChief Operating Officer, Exor · EP 133
- Alex ZhavoronkovCEO, Insilico Medicine · EP 108
- Joško BobanovićPartner, Sofinnova Partners · EP 179
- Marie SchroederNovo Holdings · EP 183
Two ways to start
Your goal, and the first step toward it.
Over 26 years in leadership roles, I have built a method that turns a big goal into a clear next move and keeps you moving until you reach it. Choose the start that fits where you are.
Your Next Move
Your next move, decided
Clarity on where you want to go, and on what you do first.
- Before
- Your onboarding letter and preparation sheet within 24 hours of booking. You send your answers back two days before the session.
- Session
- 60 minutes on Zoom.
- Afterwards
- Within 24 hours, a written de-brief with my core observations, the recommendation with the most impact and your next step, plus the recording and the transcript.
- Price
- EUR 500, one fixed price for all three steps. English or German.
First conversation · free
A first conversation
To find out whether we are a fit.
- Where
- Fifteen minutes on Zoom or Teams.
- When
- One to three weeks out, Monday to Friday.
- Preparation
- Nothing to prepare. If you like, share a line on the booking page about what is on your mind.
- Afterwards
- One first angle on your situation.